person

Philippine R.

Country
France
Department
Hématologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
3
Sites with multiple studies

Has run more than one trial at 3 of 42 partner sites.

Specializations

Hematologic malignancies

Clinical research in myelodysplastic syndromes, multiple myeloma, follicular lymphoma, and chronic lymphocytic leukemia, with additional interest in treatment approaches for haematological disorders associated with infection risk and anemia.

  • Myelodysplastic syndromes
  • Multiple myeloma
  • Follicular lymphoma
  • Chronic lymphocytic leukemia

Research activity also includes supportive and disease-control strategies relevant to transfusion dependence, neutropenia, and refractory cytopenias.

Gastrointestinal and hepatobiliary oncology

Investigator involvement covers colorectal cancer, advanced biliary tract cancer, hepatocellular carcinoma, and anal squamous cell carcinoma, with attention to both resected and metastatic disease settings.

  • Colorectal cancer
  • Advanced biliary tract cancer
  • Hepatocellular carcinoma
  • Locally advanced anal squamous cell carcinoma

The therapeutic landscape includes adjuvant, first-line, and maintenance strategies aimed at improving disease control and recurrence prevention.

Immune-mediated gastrointestinal disease

Research extends to Crohn’s disease and ulcerative colitis, with a clear focus on biologic and targeted therapies for persistent inflammatory activity and loss of response.

  • Crohn’s disease
  • Ulcerative colitis
  • Biologic therapy
  • Targeted anti-inflammatory treatment

Clinical interests include remission maintenance, biomarker-guided management, and optimization of treatment sequencing in chronic intestinal inflammation.

Dermatologic and immune-mediated disorders

The investigator is involved in studies of moderate-to-severe plaque psoriasis and prurigo nodularis, reflecting interest in chronic inflammatory skin disease and symptom burden reduction.

  • Moderate-to-severe plaque psoriasis
  • Prurigo nodularis
  • Immune-mediated skin disease
  • Long-term symptom control

These trials align with therapeutic development for persistent pruritus, cutaneous inflammation, and quality-of-life impairment.

Solid tumors and multimodal cancer therapy

Additional research spans melanoma, head and neck squamous cell carcinoma, non-small cell lung cancer, ovarian cancer, and breast cancer, including resected, locally advanced, and metastatic settings.

  • Melanoma
  • Head and neck squamous cell carcinoma
  • Non-small cell lung cancer
  • Ovarian cancer

Work in this area includes immunotherapy, adjuvant treatment, and combined-modality oncology for recurrence reduction and survival improvement.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.